{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:14:18Z","timestamp":1771006458126,"version":"3.50.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T00:00:00Z","timestamp":1351209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048259","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T20:57:48Z","timestamp":1351285068000},"page":"e48259","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia"],"prefix":"10.1371","volume":"7","author":[{"given":"Sarosh","family":"Rana","sequence":"first","affiliation":[]},{"given":"Ana Sofia","family":"Cerdeira","sequence":"additional","affiliation":[]},{"given":"Julia","family":"Wenger","sequence":"additional","affiliation":[]},{"given":"Saira","family":"Salahuddin","sequence":"additional","affiliation":[]},{"given":"Kee-Hak","family":"Lim","sequence":"additional","affiliation":[]},{"given":"Steven J.","family":"Ralston","sequence":"additional","affiliation":[]},{"given":"Ravi I.","family":"Thadhani","sequence":"additional","affiliation":[]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,10,26]]},"reference":[{"key":"ref1","first-page":"159","article-title":"Diagnosis and management of preeclampsia and eclampsia","volume":"99","author":"bulletin ACOG practice","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"B Sibai","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ajog.2006.02.012","article-title":"Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy","volume":"195","author":"W Ganzevoort","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10641950701521742","article-title":"Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes","volume":"26","author":"J Menzies","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1600-0412.2011.01111.x","article-title":"How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis","volume":"90","author":"S Thangaratinam","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"P von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"CE Powe","year":"2011","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"RJ Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"T Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"RJ Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"O Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, <etal>et al<\/etal>.. (2010) An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202: 161 e161\u2212161 e111.","DOI":"10.1016\/j.ajog.2009.09.016"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2010.02.010","article-title":"Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia","volume":"43","author":"J Schiettecatte","year":"2010","journal-title":"Clin Biochem"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Sunderji S, Gaziano E, Wothe D, Rogers LC, Sibai B, <etal>et al<\/etal>.. (2010) Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 202: 40 e41\u221247.","DOI":"10.1016\/j.ajog.2009.07.025"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"S Rana","year":"2012","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"R Thadhani","year":"2011","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"T Chaiworapongsa","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"C Kleinrouweler","year":"2012","journal-title":"BJOG"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/HYPERTENSIONAHA.111.174417","article-title":"Threshold of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for the imminent onset of preeclampsia","volume":"58","author":"A Ohkuchi","year":"2011","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJMoa0908056","article-title":"Vitamins C and E to prevent complications of pregnancy-associated hypertension","volume":"362","author":"JM Roberts","year":"2010","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators","volume":"335","author":"EM Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"T Reichlin","year":"2009","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, <etal>et al<\/etal>.. (2012) The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206: 58 e51\u221258.","DOI":"10.1016\/j.ajog.2011.07.037"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"JP Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"RW Powers","year":"2010","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00005792-198107000-00002","article-title":"Hypertension in pregnancy: clinical-pathological correlations and remote prognosis","volume":"60","author":"KA Fisher","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"SE Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"S Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0b013e3181cb9644","article-title":"Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach","volume":"115","author":"MD Lindheimer","year":"2010","journal-title":"Obstet Gynecol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:00:52Z","timestamp":1540260052000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048259"}},"subtitle":[],"editor":[{"given":"Cees","family":"Oudejans","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,10,26]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048259","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,26]]}}}